PDS Biotechnology is shifting its focus to a triplet therapy for HPV-positive cancers instead of pursuing approval for PDS0101 alone. The company's pivot raises concerns about potential delays and the ...

If you’ve ever sat on a plane wondering why the pilot announced that you’d be landing soon but seemed to be flying in circles with no runway in sight, you’ve probably been in a holding pattern.

Bitcoin is holding above $107,000 as traders digest mixed macro signals. The latest US core PCE data, the Fed's preferred gauge, came in at 2.7% year-over-year in May, above the expected 2.6%. Core ...